AKAP9 Antikörper (N-Term)
Kurzübersicht für AKAP9 Antikörper (N-Term) (ABIN203051)
Target
Alle AKAP9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Human AKAP9
-
Homologie
- Percent identity by BLAST analysis: Human, Dog, Bovine, Horse, Guinea pig (100%) Pig (92%) Chicken (91%) Mouse (85%).
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Synthetic peptide from N-Terminus of human AKAP9 (Q6PJH3). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Dog, Bovine, Horse, Guinea pig (100%), Marmoset, Pig, Opossum (92%), Galago, Bat, Chicken (91%), Mouse, Xenopus (85%), Lizard (84%).
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
anti-A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9) (AA 71-191) antibody
AKAP9 Reaktivität: Human ELISA, WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9) (AA 17-130) antibodyAKAP9 Reaktivität: Human WB, IF Wirt: Maus Monoclonal 7-AKAP450 unconjugated
anti-A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9) (C-Term) antibodyVerified AKAP9 Reaktivität: Human ELISA, WB, IF Wirt: Ziege Polyclonal unconjugated
anti-A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9) (AA 3812-3911) antibodyAKAP9 Reaktivität: Human ELISA, WB Wirt: Maus Monoclonal 1A6 unconjugated
anti-A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9) (AA 3812-3911) antibodyAKAP9 Reaktivität: Human ELISA, WB, IF Wirt: Maus Monoclonal 7E12 unconjugated
anti-A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9) (C-Term) antibodyAKAP9 Reaktivität: Human ELISA, WB, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9) (N-Term) antibodyAKAP9 Reaktivität: Human, Hund, Maus, Rind (Kuh) WB Wirt: Kaninchen Polyclonal unconjugated
anti-A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9) (N-Term) antibodyAKAP9 Reaktivität: Human, Hund, Maus, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Ratte WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Approved: WB (1.25 μg/mL)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))
-
Andere Bezeichnung
- AKAP9 / YOTIAO
-
Hintergrund
-
Name/Gene ID: AKAP9
Synonyms: AKAP9, A-kinase anchor protein 9, AKAP9-BRAF fusion protein, AKAP350, AKAP450, AKAP 350, AKAP 450, CG-NAP, AKAP 120-like protein, AKAP-9, HgAKAP 350, HYPERION, KIAA0803, Kinase N-associated protein, LQT11, PRKA9, MU-RMS-40.16A, Protein hyperion, Protein yotiao, YOTIAO, PPP1R45 -
Gen-ID
- 10142
-
UniProt
- Q99996
-
Pathways
- M Phase, SARS-CoV-2 Protein Interaktom
Target
-
